Oral Administration of PF-01247324, a Subtype-Selective Nav1.8 Blocker, Reverses Cerebellar Deficits in a Mouse Model of Multiple Sclerosis.
| Autor: | Shields, Shannon D.1,2, Butt, Richard P.3, Dib-Hajj, Sulayman D.1,2, Waxman, Stephen G.1,2 stephen.waxman@yale.edu |
|---|---|
| Zdroj: | PLoS ONE. Mar2015, Vol. 10 Issue 3, p1-8. 8p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|